We are a team of experts in their fields, who have a common goal: We want to expedite molecular diagnostics!
Head of the team is Dr. Andy Wende with over 15 years experience in research and development of molecular biology-based technologies and applications at the Max-Planck-Institute for Biochemistry and at QIAGEN.
During the 9+ years at QIAGEN, Dr. Wende has worked on multiple interdisciplinary projects in the field of rapid nucleic acid extraction and amplification for use in Point-of-Care (POC) diagnostics, which also led to 16 patent applications. He was also involved in technology scouting activities as technical advisor at QIAGEN.
Later, Dr. Wende joined TÜV SÜD Product Service (TPS) for 4+ years. TPS is the largest Notified Body for medical devices. He was part of the In-vitro-diagnostics team and was responsible for certification of IVD products as Lead Auditor for IVDR/IVDD, MDSAP, ISO 13485, ISO 9001, Taiwan GMP and as Product Assessor for high-risk IVDs.
After careful preparation and planning for more than a year, Xpedite was founded in November 2020 and launched its first product, SwiftX™ Swabs, which is validated for SARS-CoV-2 testing. Meanwhile, we have 3 different RNA and DNA extraction kits on the market, 2 of them are also CE-IVD marked.
In addition, we are an authorized distributor of rapid isothermal amplification kits from Qitian Biotechnology, which are based on Recombinase Aided Amplification (RAA) technology.